The pharmaceutical industry could potentially save $90 billion from increased efficiency. This infograph highlights interesting facts and figures as it relates to each stage of the supply chain, starting with product development. For information, visit www.PEXPharma.com Concept by Shawn Siegel. Art by Paul Kane.

1. Performance Excellence
in the Pharmaceutical Supply Chain
PRODUCT MANUFACTURING DISTRIBUTION MARKETING SAVINGS
DEVELOPMENT
Performance
$1.3 billion: $92 billion: 87%: $7 billion: $90 billion:
Excellence
The average cost of bringing The amount of name-brand The percentage of The amount 3 pharmaceutical The potential for Pharmaceutical,
Biotech and
a new drug to market. The drugs that will come off pat- prescription drug sales giants will have to pay in world-wide savings
success rate of new chemical ent in the next five years. This revenue handled by illegal marketing fines and
will put more emphasis than distributors in 2010, a settlements from the past
the pharmaceutical
compounds has fallen from
12% a decade ago to under ever on drug manufacturing, 6% increase over 2007. year. 68% of respondents in industry could reap Medical Devices
8% today.* especially in an industry chal- GlaxoSmithKline removed a recent marketing survey from increased
*Eli Lilly lenged by overcapacity* 10 days off the supply chain believe the pharmaceutical efficiency.* February 25-27, 2013
*PharmPro, PharmExec
process with a renewed model is broken and needs *Pharmaceutical Engineering The Hub: Cira Centre, Philadelphia
efficiency focus.* repair.*
*Booz & Co., Fierce Network *Bloomberg, LA Times, Booz & Co. Network and share best practices
with industry leaders from top
PRESENTATION: PRESENTATION: PRESENTATION: PRESENTATION: ROUNDTABLE: companies like AstraZeneca,
All You Need to Know About A Biopharmaceutical Getting What You Need Commercial Strategy: Advisory Board Rapid GlaxoSmithKline, and Johnson &
Product Development but Manufacturer’s Perspective When You Need It Doing More With Less Fire Round
Are Afraid to Ask With the most experienced minds
Johnson. Learn from efficiency
Case study utilizing Value Learn best strategies for selecting Boost the point of sale with key
Led by Ajay Dedhia, Director, Stream Mapping suppliers. trade marketing strategies in the industry. experts and discuss
Continuous Improvement R&D, Led by Deepa Kumar, Operational Led by Tina Patel, Associate Led by Hillary Wilson, Business Nick Ruhmann, Operational real case studies.
AstraZeneca Excellence Expert, GlaxoSmithKline Director, Boehringer Ingelheim Operations Lead, Pradaxa, Excellence Manager, National Flood
Boehringer Ingelheim Services
Diane Francisco, Director, Process
Excellence, Covance For more information,
Paul Nelson, Operational
Excellence, Shire Pharmaceuticals
please download the
brochure.
PDF
P E X P h a r m a . c o m | 1 - 8 0 0 - 8 8 2 - 8 6 8 4 | i n f o @ i q p c . c o m